|Bid||0.00 x 1100|
|Ask||122.99 x 1100|
|Day's range||106.53 - 111.12|
|52-week range||78.44 - 131.73|
|Beta (5Y monthly)||1.09|
|PE ratio (TTM)||47.09|
|Earnings date||18 Apr 2022 - 22 Apr 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||128.71|
Get ready. Tesla and Microsoft are among the tech titans that will report. Can they beat again?
Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Improvement in TAVR and TMTT businesses is expected to have contributed to Edwards Lifesciences' (EW) fourth-quarter results.